The shareholders of DocCheck AG (XTRA:AJ9) authorized a share repurchase program at its Annual General Meeting on June 1, 2011. Under the program, the company will repurchase up to 2,000,000 shares such that the number of shares repurchased and the shares held in treasury should not exceed 10% of its total share capital. The acquisition will be carried out at the option of the management board via the stock exchange or outside of the stock exchange by means of a public purchase bid addressed to all shareholders of the company. In case of acquisition via the stock exchange, the paid purchase price per share may not fall above or below 10% of the stock price of company's share in the XETRA trade or a comparable successor system, determined by the opening auction on the same trading day. In case of acquisition via a public purchase bid, the paid purchase price for each share may not fall above or below 10% of the relevant value of a share of the company. With a public purchase bid the relevant value is the stock price in XETRA-trade or a comparable successor system determined in the opening auction at the last trading day before the day of the public announcement of the purchase bid. If with the public purchase bid, the subscription exceeds the volume of the bid, the acceptance shall be based on quotas. A privileged acceptance of smaller numbers of shares up to 100 tendered shares for each shareholder can be planned. The repurchased shares will be resold in compliance with the principle of equal treatment, or in ways other than via the stock exchange or through an offer to all shareholders, or used as payments for transactions of external growth and company acquisitions, or to fulfill subscription rights attached to the securities, or can be retired. The share repurchase program will be valid for November 30, 2012.

On December 9, 2011, the company authorized a tender offer. Under the offer, the company will repurchase up to 350,000 shares, at a price of €4.25 per share, for a total cost of €1.49 million. The offer will commence on December 12, 2011 and will expire on December 22, 2011.

On December 22, 2011, company's tender offer announced on December 9, 2011, expired. Under the offer, the company repurchased 295,216 shares, at a price of €4.25 per share, for a total cost of €1.25 million. Oliver Maaß and Julie Ann Schreiber of Heisse Kursawe Eversheds acted as legal advisors to DocCheck AG in the tender offer.

DocCheck AG's share repurchase program expired on November 30, 2012.